Our investigative editor’s favorites for 2023
Big Pharma
On Drug Prices, Biden Opts for Talk Over Action
The administration says it has the ability to employ march-in rights to lower drug prices. When will it actually use them?
Actually, Opioid Victims Love the Sackler Immunity Shields
And other fake news from the Supreme Court’s Purdue Pharma hearing
The Department of Justice’s Legal Love Letter to Moderna
This story has been retracted.
The Commodification of Everything
Understanding the deeper dynamics of predatory capitalism
The Next Insulin Scandal
A generic cold medicine available in Europe also turns out to have benefits for Parkinson’s. Biden could prevent the usual effort to patent it and jack up the price.
Pharmageddon Protesters Fight for Dignity at Work
A three-day walkout is intended to highlight high stress and low pay at chain pharmacies.
The Slow Cooker of Corporate Flameouts
A band of Reddit contrarians tried to make Rite Aid the first meme stock. A truly staggering series of miscues thwarted their dreams.
Sanders Seeks Investigation of NIH Licensing Practices
The senator wants the inspector general to probe why the NIH licensed a potentially lucrative cancer drug to an obscure company linked to a former employee.
The NIH’s ‘How to Become a Billionaire’ Program
An obscure company affiliated with a former NIH employee is offered the exclusive license for a government-funded cancer drug.
